简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
abstrak:Aug 4 (Reuters) - U.S.-based private equity fund Blackstone (BX.N) will submit a bid next week to ac
Aug 4 (Reuters) - U.S.-based private equity fund Blackstone (BX.N) will submit a bid next week to acquire a 33.47% stake in Indian drugmaker Cipla (CIPL.NS), the Economic Times reported on Friday, citing sources.
The stake sale will formally start the exit of the Hamied family who had founded Cipla in 1935, the report added.
Cipla and Blackstone did not immediately respond to Reuters request for comment.
The move will also trigger an open offer for an additional 26% of Cipla, upon full subscription of which Blackstone would end up owning as much as 59.4% of Ciplas stake, according to the report.
Last Month, Moneycontrol had reported that top shareholders of the pharma major, which includes Blackstone are in talks to sell a part of their stake to private equity players.
Shares of the company have risen over 14% since the Moneycontrol report, and hit record high on Friday.
Disclaimer:
Ang mga pananaw sa artikulong ito ay kumakatawan lamang sa mga personal na pananaw ng may-akda at hindi bumubuo ng payo sa pamumuhunan para sa platform na ito. Ang platform na ito ay hindi ginagarantiyahan ang kawastuhan, pagkakumpleto at pagiging maagap na impormasyon ng artikulo, o mananagot din para sa anumang pagkawala na sanhi ng paggamit o pag-asa ng impormasyon ng artikulo.